These results were consistent with previous findings in non–small‐cell lung cancer17 and prostate cancer,22 and further suggest that MEG3 may serve as a novel tumour suppressive LncRNA to regulate laryngeal carcinogenesis. The gene discussed is MEG3; the disease is prostate carcinoma.